<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tendulkar S</submitter><funding>Science and Engineering Board</funding><funding>NHGRI NIH HHS</funding><funding>Indian Institute of Science Education and Research</funding><funding>Agharkar Research Institute</funding><funding>Council for Scientific and Industrial Research</funding><funding>NIGMS NIH HHS</funding><funding>NIH HHS</funding><pagination>2857-2875</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9433731</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>31(17)</volume><pubmed_abstract>Amyotrophic lateral sclerosis (ALS) is a fatal, late-onset, progressive motor neurodegenerative disorder. A key pathological feature of the disease is the presence of heavily ubiquitinated protein inclusions. Both the unfolded protein response and the ubiquitin-proteasome system appear significantly impaired in patients and animal models of ALS. We have studied cellular and molecular mechanisms involved in ALS using a vesicle-associated membrane protein-associated protein B (VAPB/ALS8) Drosophila model [Moustaqim-Barrette, A., Lin, Y.Q., Pradhan, S., Neely, G.G., Bellen, H.J. and Tsuda, H. (2014) The ALS 8 protein, VAP, is required for ER protein quality control. Hum. Mol. Genet., 23, 1975-1989], which mimics many systemic aspects of the human disease. Here, we show that VAPB, located on t</pubmed_abstract><journal>Human molecular genetics</journal><pubmed_title>Caspar, an adapter for VAPB and TER94, modulates the progression of ALS8 by regulating IMD/NFκB-mediated glial inflammation in a Drosophila model of human disease.</pubmed_title><pmcid>PMC9433731</pmcid><funding_grant_id>U41 HG000739</funding_grant_id><funding_grant_id>P40 OD010949</funding_grant_id><funding_grant_id>R01 GM084947</funding_grant_id><funding_grant_id>P40 OD018537</funding_grant_id><pubmed_authors>Thulasidharan A</pubmed_authors><pubmed_authors>Tendulkar S</pubmed_authors><pubmed_authors>Ratnaparkhi A</pubmed_authors><pubmed_authors>Ratnaparkhi GS</pubmed_authors><pubmed_authors>Hegde S</pubmed_authors><pubmed_authors>Kaduskar B</pubmed_authors><pubmed_authors>Garg L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Caspar, an adapter for VAPB and TER94, modulates the progression of ALS8 by regulating IMD/NFκB-mediated glial inflammation in a Drosophila model of human disease.</name><description>Amyotrophic lateral sclerosis (ALS) is a fatal, late-onset, progressive motor neurodegenerative disorder. A key pathological feature of the disease is the presence of heavily ubiquitinated protein inclusions. Both the unfolded protein response and the ubiquitin-proteasome system appear significantly impaired in patients and animal models of ALS. We have studied cellular and molecular mechanisms involved in ALS using a vesicle-associated membrane protein-associated protein B (VAPB/ALS8) Drosophila model [Moustaqim-Barrette, A., Lin, Y.Q., Pradhan, S., Neely, G.G., Bellen, H.J. and Tsuda, H. (2014) The ALS 8 protein, VAP, is required for ER protein quality control. Hum. Mol. Genet., 23, 1975-1989], which mimics many systemic aspects of the human disease. Here, we show that VAPB, located on t</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-04T21:35:17.37Z</modification><creation>2024-11-10T06:30:29.572Z</creation></dates><accession>S-EPMC9433731</accession><cross_references><pubmed>35377453</pubmed><doi>10.1093/hmg/ddac076</doi></cross_references></HashMap>